Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics hypoxia inducible factors'

Search results for: 'research area epigenetics hypoxia inducible factors'

Items 31-40 of 114

Page
per page
  1. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  2. Zebularine
    A1915 Zebularine
     1 Citation
    Target: DNA Methyltransferases|Cytidine deaminases
    Summary: DNA methylation inhibitor
      insoluble in EtOH; ≥50.7 mg/mL
  3. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor,highly potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
  4. Tubastatin A HCl
    A8547 Tubastatin A HCl
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent and selective
      insoluble in EtOH; ≥12.34 mg/mL
  5. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  6. Trichostatin A (TSA)
    A8183 Trichostatin A (TSA)
     13 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; ≥15.12 mg/mL
  7. JNJ-26481585
    A4090 JNJ-26481585
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Potent HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.2 mg/mL
  8. UPF 1069
    A4163 UPF 1069
    Target: PARP
    Summary: Selective PARP2 inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  9. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  10. CI994 (Tacedinaline)
    A4102 CI994 (Tacedinaline)
     1 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥50 mg/mL

Items 31-40 of 114

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 113item
  2. Natural Products 2item
Reversibility
  1. Reversible 5item
  2. Irreversible 1 item
Target
  1. Caspases 1 item
  2. Cyclin-Dependent Kinases 1 item
  3. Proteasome 1 item
  4. Histone Deacetylases (HDACs) 16item
  5. Bcl-2 1 item
  6. PI3K 1 item
  7. Raf 1 item
  8. Aurora Kinases 7item
  9. Bcl-xl 1 item
  10. CSF-1R 1 item
  11. EZH2 1 item
  12. Bromodomains 1 item
  13. AP-1 2item
  14. MMP 2item
  15. DT-diaphorases 1 item
  16. FLT3 1 item
  17. Factor Xa 3item
  18. LPA Receptors 1 item
  19. PLK 1 item
  20. VEGFR 8item
  21. PDGFR 4item
  22. c-Kit 2item
  23. Bromodomain-containing proteins(BRDs) 1 item
  24. Mcl-1 1 item
  25. Hydrolase 1 item
  26. SGK 1 item
  27. DOT1L 1 item
  28. FGFR 3item
  29. Nrf2 1 item
  30. Insulin-like growth factor receptors(IGFRs) 1 item
  31. Pim 1 item
  32. Sir2-like Family Deacetylases (Sirtuins) 3item
  33. Deubiquitinating enzymes (DUBs) 1 item
  34. PP1 1 item
  35. PP2A 1 item
  36. Smoothened 1 item
  37. MET 1 item
  38. STAT 1 item
  39. EGFR 5item
  40. RIP kinases 1 item
  41. Hypoxia Inducible Factors (HIFs) 1 item
  42. JAK 4item
  43. DNA-PK 1 item
  44. HSP90 1 item
  45. Topoisomerases 1 item
  46. ErbB 2item
  47. Toll-like receptors (TLRs) 1 item
  48. Actin 1 item
  49. DNA Methyltransferases 2item
  50. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  51. ERK 1 item
  52. CREBBP 1 item
  53. EP300 1 item
  54. Lyn 1 item
  55. HER2 1 item
  56. Insulin and Insulin-like Receptors 2item
  57. PARP 1 item
  58. CB1 Receptors 1 item
  59. Dehydrogenase 1 item
  60. Fatty-acid-binding proteins (FABPs) 1 item
  61. Free Fatty Acid Receptors 1 item
  62. phosphatases 1 item
  63. Autophagy 2item
  64. C5a receptors 1 item
  65. Farnesyl Diphosphate Synthases 1 item
  66. MAGL 1 item
  67. TRP Channel 2item
  68. NO Donors / Precursors 2item
  69. CB2 Receptors 1 item
  70. IL Receptors 1 item
  71. 15-lipoxygenases 1 item
  72. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  73. Cytidine deaminases 1 item
  74. PP4 1 item
  75. c-RET 1 item
  76. c-Fms tyrosine kinase 1 item
  77. Elastases 1 item
  78. Sirtuin 1 item
Related Disease
  1. Acute Lung Injury 1 item
  2. Acute Myeloid Leukemia 8item
  3. Adrenocortical Carcinoma 1 item
  4. Bladder Cancer 4item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 27item
  7. Cancer 77item
  8. Cervical Cancer 2item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Chronic Myeloproliferative Disorders 1 item
  11. Colon Cancer 10item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 9item
  14. Diabetes 1 item
  15. Glioblastoma 8item
  16. Glioma 2item
  17. Hepatic Cancer 1 item
  18. Hepatocellular Carcinoma 1 item
  19. HIV Infections 1 item
  20. Inflammatory Diseases 2item
  21. Leukemia 3item
  22. Liver Cancer 2item
  23. Lung Cancer 8item
  24. Lung Carcinoma 1 item
  25. Lymphoma 5item
  26. Melanoma 5item
  27. Mixed Lineage Leukemia 1 item
  28. Multiple Myeloma 7item
  29. Myelofibrosis 2item
  30. Myeloma 2item
  31. Neuroblastoma 1 item
  32. Neuronal Protection 1 item
  33. Non-small Cell Lung Cancer 7item
  34. Ovarian Cancer 9item
  35. Pain Relief 1 item
  36. Pancreatic Cancer 11item
  37. Prostate Cancer 17item
  38. Psoriasis 1 item
  39. Pulmonary Arterial Hypertension 1 item
  40. Pulmonary Fibrosis 1 item
  41. Renal Cancer 1 item
  42. Renal Cell Carcinoma 5item
  43. Rheumatoid Arthritis 2item
  44. Sleep Disorders 1 item
  45. Soft Tissue Sarcoma 1 item
  46. Testicular Cancer 1 item
  47. Thyroid Cancer 2item
  48. Type 2 Diabetes 3item